List of STARLIMS Customers
STARLIMS
4000 Hollywood Blvd, Suite 333 South,
Hollywood, 33021, FL,
United States
Hollywood, 33021, FL,
United States
1 954-964-8663
Professional Services
270
$37M
Since 2010, our global team of researchers has been studying STARLIMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased STARLIMS for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using STARLIMS for Laboratory Management include: Eli Lilly, a United States based Life Sciences organisation with 50605 employees and revenues of $65.18 billion, Bayer, a Germany based Life Sciences organisation with 92815 employees and revenues of $55.47 billion, GSK, a United Kingdom based Life Sciences organisation with 69310 employees and revenues of $42.21 billion, Medline, a United States based Life Sciences organisation with 38000 employees and revenues of $21.20 billion, Synergy, a United States based Government organisation with 13000 employees and revenues of $12.72 billion and many others.
Contact us if you need a completed and verified list of companies using STARLIMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The STARLIMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTA | Non Profit | 30 | $2M | Costa Rica | STARLIMS | STARLIMS | Laboratory Management | 2012 | n/a |
In 2012 ASTA deployed STARLIMS at the National Neonatal Screening Laboratory to manage the countrywide neonatal blood screening program for inherited metabolic and hormonal disorders. STARLIMS was applied to the laboratory environment that processes approximately 1,500 tests per week from collection centers around Costa Rica, providing a centralized Laboratory Management platform to govern sample lifecycle and reporting.
STARLIMS was configured with defined modules for registration and coding, digitization, hormones and hemoglobins, amino acids and acylcarnitines, biochemistry, genetics and metabolism service, quality management, and information technology. The implementation leveraged STARLIMS querying and reporting modules, a communications and notes attached documents registry, configurable real-time alerts, barcoding and automated sample tracking, automated scheduling for second sample processing, a full audit trail for each patient and sample, and centralized demographic and results data within the STARLIMS system.
The deployment integrated STARLIMS with laboratory instrumentation and with clinical and administrative departments, enabling direct importation of analytical results via file import keyed by sample number and automated transmission of results to relevant personnel and departments. Operational coverage included the National Neonatal Screening Laboratory and collection centers across the country, and the system connected the laboratory to other software and databases to improve data manipulation and interpretation while maintaining centralized traceability.
Governance and workflow changes included permissioned access to the communications log and notes module, configurable alert parameters to flag abnormal or inconclusive results and to trigger second sample requests, and automated scheduling to prevent confusion between first and second samples. Reported outcomes from the deployment included reduction in turnaround time from sample receipt to results reporting from 72 hours to 28 hours, a reported 95% increase in laboratory efficiency, reduction of digitization time from 30 days to one day, and elimination of sample tracking errors.
|
 |
Bayer | Life Sciences | 92815 | $55.5B | Germany | STARLIMS | STARLIMS | Laboratory Management | 2024 | n/a |
In 2024, Bayer operates STARLIMS as its centralized Laboratory Management platform across Crop Protection regulatory and GxP laboratories, reflecting a 14 year partnership that centralizes global lab data and compliance workflows. STARLIMS is used to consolidate laboratory information management, supporting core laboratory functions and governance within Bayer Regulatory Science.
The deployment implements STARLIMS modules that manage recipes, batches, samples, results entry, and reporting, together with meticulous audit trailing for every laboratory interaction. Bayer uses the STARLIMS Laboratory Execution System LES on mobile devices to provide procedural guidance and immediate data capture, enabling GLP compliant documentation and in-lab execution control.
Configuration emphasizes flexibility for instrument connectivity and configurable analysis specifications, allowing individual labs to adapt workflows and reporting to local regulatory requirements. Operational coverage includes Bayer Crop Protection regulatory and GxP labs globally, with lab technicians and the Regulatory Science team using STARLIMS for day to day sample lifecycle management and field data capture.
Governance and rollout were driven by documented user requirements, procedures, and prioritized workflows, enabling standardization of laboratory practices and automation of data capture. The implementation has resulted in optimized data capture, stronger audit trails, and streamlined compliance management across Bayer’s regulated laboratories.
|
 |
Carabao | Professional Services | 10 | $2M | Thailand | STARLIMS | STARLIMS | Laboratory Management | 2023 | n/a |
In 2023, Carabao implemented STARLIMS to support energy drink QC testing, deploying the STARLIMS Platform and the STARLIMS QM Platform as its Laboratory Management solution for quality control and lab operations in Thailand. The deployment centers on STARLIMS as the primary Laboratory Management application to enable automated and digitalized QC workflows for samples and test results.
The implementation configures the STARLIMS QM Platform to provide automated sample and test workflow orchestration, electronic data capture, configurable quality management controls, audit trails, and a searchable data repository, delivering a high level of automation and digitalization. Data created and managed in STARLIMS is accessible and searchable in real time and protected against loss or manipulation, supporting data integrity and traceability for laboratory records.
Operational scope focused on Carabao’s quality control laboratory functions, impacting quality control, lab operations, and compliance with internal SOPs. Governance and process changes emphasized digital recordkeeping and standardized SOP enforcement, and the STARLIMS QM Platform helped Carabao meet compliance initiatives while freeing up personnel hours and increasing confidence in QC operations and data management.
|
 |
Douglas Pharmaceuticals | Life Sciences | 770 | $86M | New Zealand | STARLIMS | STARLIMS | Laboratory Management | 2021 | n/a |
In 2021, Douglas Pharmaceuticals implemented STARLIMS, deploying Laboratory Management capabilities across its New Zealand Quality Control Department as part of a Smart Labs program. The implementation followed capacity and utilization studies and was explicitly tied to Lean Transformation goals that targeted over 20% efficiency gains to support growth while minimizing headcount expansion.
STARLIMS was configured to centralize and standardize QC workflows, providing sample lifecycle management, stability study management, microbiology sample management and QC result capture. The deployment included a custom reporting engine and role based access with audit trail and electronic signature functionality to support GMP compliance and quality assurance.
The project delivered instrument connectivity and wider enterprise systems integration to automate data ingestion and reduce manual handoffs between lab instruments and business systems. Operational coverage began in the regulated Quality Control Department and was extended into a shared services model, with plans to roll STARLIMS out to additional laboratory sites to consolidate testing and increase utilization.
Governance changes accompanied the technical rollout, combining organizational structure review, centralization of services and elimination of noncore activities to realize lean benefits. Douglas retained support and training to manage and configure STARLIMS in house, and reported outcomes that include improved compliance and competitiveness, reduced printing and storage costs, an increase in DIFOT from 50% to 95% and a 50% reduction in Laboratory Investigation Reports.
|
 |
Dr Lal PathLabs Ltd (LPL) | Healthcare | 4048 | $243M | India | STARLIMS | STARLIMS | Laboratory Management | 2023 | n/a |
In 2023, Dr Lal PathLabs Ltd implemented STARLIMS as its Laboratory Management solution to standardize and scale informatics across an enterprise network that includes more than 230 laboratories, over 3,700 patient service centers, and 9,000 pickup points. The STARLIMS LIMS and Scientific Data Management System was chosen to address limitations of an outdated laboratory information system and to provide a single platform for workflow automation, reporting, and advanced data handling across the organization.
The deployment emphasized core laboratory modules and automation capabilities, including sample management, test scheduling, automated result capture, a reporting engine configured for more than 4,000 tests, and an instrument interface layer. Configuration work delivered managed instrument maintenance and validation, role based access controls, full workflow transparency, and an end to end audit trail, enabling coordinated lifecycle management from collection through results reporting.
Integrations were implemented at scale, with STARLIMS interfacing to more than 1,000 diverse instruments across hundreds of sites, as well as to robotic sample management tracks and automation arms, third party quality control programs, and emerging digital pathology and bioinformatics pipelines. Operational coverage spans laboratory departments with department specific menus and workflows, plus satellite facilities and newly acquired laboratories, allowing the Laboratory Management platform to extend as facilities and test menus expand.
Governance and rollout followed a conventional system development lifecycle, with dedicated teams from STARLIMS working closely with LPL over an extended configuration period, joint responsibility for requirement gathering, form and workflow design, user acceptance testing, and go live support. The program incorporated regular status reviews across hierarchies, explicit change management actions, and transparent leadership directives to manage scope, timelines, and stakeholder adoption.
Explicit results documented by LPL include hands off automation that supports processing for up to 100,000 patients per day, elimination of manual transcription and transfer steps, a threefold increase in sample handling capacity using automation, integration with 1,000 plus instruments for faster data transfer, and generation of content rich reports for a wide test menu. The STARLIMS Laboratory Management deployment therefore delivered scaled automation, broader instrument interoperability, stronger data integrity and security, and centralized reporting capabilities across Dr Lal PathLabs Ltd.
|
 |
|
Oil, Gas and Chemicals | 24000 | $12.4B | United States | STARLIMS | STARLIMS | Laboratory Management | 2021 | n/a |
|
|
|
|
Life Sciences | 50605 | $65.2B | United States | STARLIMS | STARLIMS | Laboratory Management | 2015 | n/a |
|
|
|
|
Life Sciences | 69310 | $42.2B | United Kingdom | STARLIMS | STARLIMS | Laboratory Management | 2021 | n/a |
|
|
|
|
Oil, Gas and Chemicals | 150 | $20M | Spain | STARLIMS | STARLIMS | Laboratory Management | 2009 | n/a |
|
|
|
|
Life Sciences | 38000 | $21.2B | United States | STARLIMS | STARLIMS | Laboratory Management | 2020 | n/a |
|
Showing 1 to 10 of 16 entries
Buyer Intent: Companies Evaluating STARLIMS
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating STARLIMS. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating STARLIMS for Laboratory Management include:
- Lonza, a Switzerland based Life Sciences organization with 17834 Employees
- Knauf, a Germany based Manufacturing company with 41000 Employees
- Certimin Peru, a Peru based Professional Services organization with 382 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated |
|---|---|---|---|---|---|---|
 |
Lonza | Life Sciences | 17834 | $7.6B | Switzerland | 2026-03-05 |
 |
Knauf | Manufacturing | 41000 | $16.7B | Germany | 2026-02-11 |
|
Certimin Peru | Professional Services | 382 | $40M | Peru | 2026-01-07 |
|
|
Banking and Financial Services | 80000 | $61.8B | United States | 2025-12-01 |
FAQ - APPS RUN THE WORLD STARLIMS Coverage
STARLIMS is a Laboratory Management solution from STARLIMS.
Companies worldwide use STARLIMS, from small firms to large enterprises across 21+ industries.
Organizations such as Eli Lilly, Bayer, GSK, Medline and Synergy are recorded users of
STARLIMS for Laboratory Management.
Companies using STARLIMS are most concentrated in Life Sciences and Government, with adoption spanning over 21 industries.
Companies using STARLIMS are most concentrated in United States, Germany and United Kingdom, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of STARLIMS across Americas, EMEA, and APAC.
Companies using STARLIMS range from small businesses with 0-100 employees - 12.5%, to mid-sized firms with 101-1,000 employees - 25%, large organizations with 1,001-10,000 employees - 18.75%, and global enterprises with 10,000+ employees - 43.75%.
Customers of STARLIMS include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified STARLIMS customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Laboratory Management.